Significant Ownership of Bellevue Group AG
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Bellevue Group AG focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Stefano Montalbano - Stefano Montalbano/ Chief Financial Officer
- Manager location
- Zurich
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Bellevue Group AG with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Bellevue Group AG
Significant Ownership of Bellevue Group AG
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| JBIO | Jade Biosciences, Inc. | Common Stock | 6.8% | $46,307,688 | 3,341,103 | Bellevue Group AG | 16 Dec 2025 | ||
| VRDN | Viridian Therapeutics, Inc. | Common Stock | 6.6% | $93,493,402 | 6,726,144 | Bellevue Group AG | 31 Mar 2026 | ||
| IMCR | Immunocore Holdings plc | Ordinary shares | 5.6% | $101,607,853 | 2,796,803 | Bellevue Group AG | 20 Aug 2025 | ||
| CLDX | Celldex Therapeutics, Inc. | Common Stock | 1.5% | $37,512,000 | -$75,576,333 | 1,200,000 | -67% | Bellevue Group AG | 31 Mar 2026 |
| MGNX | MacroGenics, Inc. | Common Stock | 0% | $0 | -$13,901,948 | 0 | -100% | Bellevue Group AG | 05 Dec 2025 |
| AGIO | Agios Pharmaceuticals, Inc. | Common Stock | 0% | $0 | -$142,398,726 | 0 | -100% | Bellevue Group AG | 19 Nov 2025 |
Schedules 13D/G Reported by Bellevue Group AG:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.